Baystate Wealth Management’s Silver Standard Resources SSRI Stock Holding History

Baystate Wealth Management’s Portfolio SSRI Stock Details SSRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,000	Closed	-$29K	–	724
2017 Q2	$29K	Hold	3,000	–	–	0.01%	235
2017 Q1	$34K	Hold	3,000	–	–	0.01%	210
2016 Q4	$29K	Buy	+3,000	New	+$30.3K	0.01%	199
2013 Q3	–	Sell	-3,000	Closed	-$19K	–	284
2013 Q2	$19K	Buy	+3,000	New	+$22.1K	0.01%	156

Other funds holding SSRI

SCP

Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return

Baystate Wealth Management's SSRI Position: Q3 2017 in Review

Baystate Wealth Management sold out of Silver Standard Resources (SSRI) in Q3 2017, closing a stake of 3,000 shares — an estimated $29K sold.

Baystate Wealth Management first reported a position in SSRI in Q2 2013 and held it in 4 quarters. The position peaked at $34K in Q1 2017. 1 fund tracked by Wall St. Rank holds SSRI as of Q3 2017.

Baystate Wealth Management reported no remaining Silver Standard Resources position as of Q3 2017 after selling out during the quarter.
Baystate Wealth Management sold 3,000 Silver Standard Resources shares in Q3 2017, an estimated $29K.
Baystate Wealth Management first reported a position in Silver Standard Resources in Q2 2013 and held it in 4 quarters.
Baystate Wealth Management's Silver Standard Resources position peaked at $34K in Q1 2017.
1 fund tracked by Wall St. Rank held Silver Standard Resources as of Q3 2017.

Based on Baystate Wealth Management's 13F filing for Q3 2017, filed 10 Oct 2017.